Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 4—April 2026

Research

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023–2024

Denis NiyomwungereComments to Author , Pierre Sinarinzi, Emmanuelle Caspar, Lucas Thiebaut, Pierre-Emeric Strubel, Yssimini Nadège Guillène Tibiri, Laurence Ma, Jérôme Rurihafi, Pierre Ndizeyimana, Pierre Hakizimana, Nestor Niyizompa, Adélin Witonze, Vénant Ndayiragije, Floride Ndayisenga, Malachie Ndikumukiza, Olive Niyonkuru, Jean Claude Niyonsaba, Césaire Bangirinama, Jolis Lazare Bigirimana, Nicaise Ntahondi, Landrine Mugisha, Marcelline Nibakire, Néhémie Nzoyikorera, Denis Sinzinkayo, Didier MenardComments to Author , and Joseph Nyandwi
Author affiliation: Institut National de Santé Publique, Bujumbura, Burundi (D. Niyomwungere, P. Ndizeyimana, P. Hakizimana, J. Nyandwi); Programme National Intégré de Lutte contre le Paludisme, Bujumbura (P. Sinarinzi, J. Rurihafi, N. Niyizompa, A. Witonze, F. Ndayisenga, L. Mugisha, M. Nibakire, N. Nzoyikorera); Malaria Genetics and Resistance Team, Pathogens Host Arthropods Vectors Interactions Unit, University of Strasbourg, Strasbourg, France (E. Caspar, L. Thiebaut, P.-E. Strubel, Y.N.G. Tibiri, D. Menard); Institut de Recherche en Sciences de la Santé, Clinical Research Unit of Nanoro, Nanoro, Burkina Faso (Y.N.G. Tibiri); Biomics Platform, Institut Pasteur, Université Paris Cite, Paris, France (L. Ma); Centre Hospitalo-universitaire de Kamenge, Bujumbura (V. Ndayiragije, M. Ndikumukiza, O. Niyonkuru, C. Bangirinama, J.L. Bigirimana, N. Ntahondi); Université du Burundi, Bujumbura (M. Ndikumukiza, D. Sinzinkayo, J. Nyandwi); Tanganyika Care Hospital, Bujumbura (J.C. Niyonsaba); Malaria Parasite Biology and Vaccines, INSERM Unit 1347, ParasitInnov, Institut Pasteur, Université Paris Cité, Paris (D. Menard); Laboratory of Parasitology and Medical Mycology, CHU Strasbourg, Strasbourg (D. Menard); Institut universitaire de France, Paris (D. Menard)

Main Article

Figure

Locations of 8 sentinel health facilities used for study of border region surveillance of malaria drug resistance, northern Burundi, 2023–2024. Red crosses show locations of participating health facilities across the provinces of Ngozi and Kirundo, where clinical and molecular surveillance of artemisinin partial resistance was conducted during December 2023–June 2024. District health facilities included were in Ngozi, Kiremba, and Buye in Ngozi Province and Kirundo and Vumbi in Kirondo Province. Inset shows bordering countries in Africa.

Figure. Locations of 8 sentinel health facilities used for study of border region surveillance of malaria drug resistance, northern Burundi, 2023–2024. Red crosses show locations of participating health facilities across the provinces of Ngozi and Kirundo, where clinical and molecular surveillance of artemisinin partial resistance was conducted during December 2023–June 2024. District health facilities included were in Ngozi, Kiremba, and Buye in Ngozi Province and Kirundo and Vumbi in Kirondo Province. Inset shows bordering countries in Africa.

Main Article

Page created: March 10, 2026
Page updated: April 15, 2026
Page reviewed: April 15, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external